GlaxoSmithKline in deal with MD Anderson on cancer drugs

(Reuters) - GlaxoSmithKline signed a collaboration agreement with the MD Anderson Cancer Center in Houston to develop new drugs that promote a patient's immune system to attack cancer based on discoveries by Anderson researchers.

via Reuters: Health News Read More Here..